Tarsus Pharmaceuticals Inc (TARS)
46.65
+0.15
(+0.32%)
USD |
NASDAQ |
Nov 14, 16:00
46.49
-0.16
(-0.34%)
After-Hours: 16:36
Tarsus Pharmaceuticals Shareholders Equity (Quarterly): 252.25M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 252.25M |
| March 31, 2024 | 275.21M |
| December 31, 2023 | 196.99M |
| September 30, 2023 | 213.66M |
| June 30, 2023 | 147.73M |
| March 31, 2023 | 173.40M |
| December 31, 2022 | 192.90M |
| September 30, 2022 | 202.63M |
| June 30, 2022 | 221.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 149.20M |
| December 31, 2021 | 166.73M |
| September 30, 2021 | 179.14M |
| June 30, 2021 | 192.47M |
| March 31, 2021 | 183.23M |
| December 31, 2020 | 165.98M |
| September 30, 2020 | -17.83M |
| June 30, 2020 | 52.37M |
| December 31, 2019 | -6.005M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-17.83M
Minimum
Sep 2020
275.21M
Maximum
Mar 2024
163.42M
Average
181.19M
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 178.82M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 376.84M |
| Total Liabilities (Quarterly) | 124.60M |
| Debt to Equity Ratio | 0.2838 |
| Current Ratio | 7.031 |
| Net Debt Paydown Yield | -0.91% |